Treatment Horizons

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Sun Blocked A new study examines non-melanoma skin cancers & HIV by Chael Needle In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...

Shock Value Research on SMYD2 shows potential to wake up the HIV reservoir by Chael Needle HIV latency—where HIV hides out in reservoirs, dormant and beyond the...

A newly approved anti-diarrheal agent seeks to counter side effects of HAART by Chael Needle Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

LifeGuide Blocking the First Step A silk-protein film aims to become an HIV prevention method by Chael Needle   When we think of HIV prevention in sexually active...

A Treatment for Lipodystrophy-Related Excessive Abdominal Fat Comes of Age by Chael Needle HIV-associated lipodystrophy, abnormalities in metabolism and/or distribution of fat in those living with...

Not So Complicated Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care by Chael Needle Alisson Sombredero, MD, is more than two months into her...

LifeGuide Rapid Response Why advances in point-of-care TB diagnostics determine the future of the AIDS crisis by Mariel Selbovitz, MPH   TB—one of the greatest killers and what appears...